logo

For the Inventor, By the Inventor

Sesto San Giovanni, Italy

Enrico Ferrari

This inventor holds 4 USPTO granted patents. Top assignee: Mediolanum Farmaceutici. Active years: 1993-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Enrico Ferrari. Retrieved from https://idiyas.com/inventor/enrico-ferrari-d4osd9r4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • Sesto San Giovanni, IT (1993 - 1994)
  • Milan, IT (1994)
  • Giovanni, IT (1995)

Company Filing History:

goldMedal4 out of 13 
 
Mediolanum Farmaceutici
 patents

Years Active: 1993-1995

Loading Chart...
4 patents (USPTO):Explore Patents
1. 5424451 - Process for preparing aminoalkylcarbamic esters of eseroline (1995-06-13),
2. 5352810 - Phosphatidylinositol analogues, inhibitors of phosphatidylinositol (1994-10-04),
3. 5302593 - Aminoalkylcarbamic esters of eseroline suitable for use as (1994-04-12),
4. 5214180 - Highly pure phosphatidylinositol of natural source useful for the (1993-05-25),

Title: Enrico Ferrari: Innovator in Pharmaceutical Chemistry

Introduction

Enrico Ferrari is a notable inventor based in Sesto San Giovanni, Italy. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work focuses on developing innovative compounds that have potential therapeutic applications.

Latest Patents

Ferrari's latest patents include a process for preparing aminoalkylcarbamic esters of eseroline, which are suitable for use as cholinesterase activity inhibitors. These compounds have a general formula where R represents an amine selected from a specific group. Additionally, he has developed phosphatidylinositol analogues that act as inhibitors of phosphatidylinositol-specific phospholipase C. These analogues are designed for preparing pharmaceutical compositions aimed at treating tumoral, thrombotic, and inflammatory pathologies.

Career Highlights

Enrico Ferrari is currently associated with Mediolanum Farmaceutici S.p.a., where he continues to advance his research and development efforts. His work has been instrumental in creating new therapeutic options for various medical conditions.

Collaborations

Ferrari has collaborated with notable colleagues such as Mario Brufani and Pier G Pagella, contributing to a dynamic research environment that fosters innovation.

Conclusion

Enrico Ferrari's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…